Project Grant HT94252510393
Award Date 8/15/25
Completion Date 8/14/29
Dollars Obligated $2.7M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15260, USA
Similar Awards
- This federal Project Grant award for $434,722 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides funding to the University of Pittsburgh to conduct a collaborative multiomic study of pediatric scleroderma. The project aims to molecularly characterize and stratify patients with this rare autoimmune disorder through a multidisciplinary research approach. The 4-year award, which commenced on August 15, 2025, will support the University of...
- The University of Pittsburgh was awarded a $494,458 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year grant will fund research to regulate profibrotic SPP1-expressing macrophages by TFEB in SSc. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care through innovative medical...
- The University of Pittsburgh is the recipient of a $1,272,000 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420). The grant, titled "The Pittsburgh ASPIRES Bridge Builder Project: Connecting Advocates, Scientists, Patients, and Institutions for Research Expansion in Sarcoma," is intended to support advanced biomedical research focused on transforming healthcare for military service members, veterans, and the broader public....
- The University of Pittsburgh received a three-year Project Grant award of $692,838 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program. The grant will fund research into scleroderma-associated interstitial lung disease, the most common cause of death for patients with systemic sclerosis. Through June 2025, the University of Pittsburgh will investigate medical solutions for this complication as part of the program's mission...
- This Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), provides $2,454,969.00 in funding to the University of Pittsburgh to conduct research on "Biomechanical and Physiological Resilience and Recovery in Load Carriage." The research aims to transform healthcare for military service members and the broader public by advancing biomedical knowledge and developing innovative medical solutions. The award period...
- The University of Pittsburgh has been awarded a $726,989 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct research on "IMMUNOTHERAPEUTIC TARGETING OF SLC39A9 IN CDKN2A-LOW MELANOMA." The three-year award, commencing on September 15, 2025, aims to advance biomedical research to transform healthcare for military service members, veterans, and the broader public. The research project will investigate medical...
- This $300,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by the University of Pittsburgh to uncover the nuclear antigens recognized by autoreactive T cells in systemic lupus erythematosus (SLE). The research aims to transform healthcare for military service members and the broader public by advancing scientific understanding of this autoimmune disease. The project will be conducted over a period...
- The University of Pittsburgh was awarded a $2,806,431.00 Project Grant on July 1, 2023 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to optimize small molecule therapeutics to treat focal segmental glomerulosclerosis. This basic, applied, and advanced biomedical research aims to transform health care by developing innovative and impactful medical solutions for Service Members and the American public. The University of Pittsburgh will...
- This federal Project Grant award of $673,197.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research conducted by the University of Pittsburgh to harmonize and analyze multi-omic data on severe traumatic brain injury. The research aims to transform healthcare for military service members and the broader public by developing innovative medical solutions to address critical health challenges. The project will be...
- The University of Pittsburgh was awarded a $954,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from May 2023 to May 2026 aimed at epigenetic reprogramming to target senescent ovarian cancer cells and overcome therapeutic resistance. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...